全文获取类型
收费全文 | 2359篇 |
免费 | 143篇 |
国内免费 | 1篇 |
专业分类
电工技术 | 25篇 |
综合类 | 10篇 |
化学工业 | 786篇 |
金属工艺 | 40篇 |
机械仪表 | 24篇 |
建筑科学 | 73篇 |
矿业工程 | 7篇 |
能源动力 | 56篇 |
轻工业 | 260篇 |
水利工程 | 19篇 |
石油天然气 | 11篇 |
无线电 | 138篇 |
一般工业技术 | 434篇 |
冶金工业 | 346篇 |
原子能技术 | 3篇 |
自动化技术 | 271篇 |
出版年
2023年 | 45篇 |
2022年 | 131篇 |
2021年 | 164篇 |
2020年 | 76篇 |
2019年 | 64篇 |
2018年 | 88篇 |
2017年 | 68篇 |
2016年 | 89篇 |
2015年 | 82篇 |
2014年 | 84篇 |
2013年 | 153篇 |
2012年 | 129篇 |
2011年 | 156篇 |
2010年 | 104篇 |
2009年 | 99篇 |
2008年 | 95篇 |
2007年 | 99篇 |
2006年 | 80篇 |
2005年 | 67篇 |
2004年 | 64篇 |
2003年 | 48篇 |
2002年 | 50篇 |
2001年 | 28篇 |
2000年 | 27篇 |
1999年 | 15篇 |
1998年 | 58篇 |
1997年 | 31篇 |
1996年 | 24篇 |
1995年 | 24篇 |
1994年 | 20篇 |
1993年 | 32篇 |
1992年 | 16篇 |
1991年 | 16篇 |
1990年 | 15篇 |
1989年 | 12篇 |
1988年 | 11篇 |
1987年 | 8篇 |
1986年 | 13篇 |
1985年 | 13篇 |
1984年 | 5篇 |
1983年 | 4篇 |
1982年 | 8篇 |
1981年 | 13篇 |
1980年 | 8篇 |
1979年 | 13篇 |
1978年 | 4篇 |
1977年 | 13篇 |
1976年 | 10篇 |
1975年 | 5篇 |
1974年 | 6篇 |
排序方式: 共有2503条查询结果,搜索用时 15 毫秒
971.
Ann-Katrin Holik Kerstin Schweiger Verena Stoeger Barbara Lieder Angelika Reiner Muhammet Zopun Julia K. Hoi Nicole Kretschy Mark M. Somoza Stephan Kriwanek Marc Pignitter Veronika Somoza 《International journal of molecular sciences》2021,22(11)
Among mammals, serotonin is predominantly found in the gastrointestinal tract, where it has been shown to participate in pathway-regulating satiation. For the stomach, vascular serotonin release induced by gastric distension is thought to chiefly contribute to satiation after food intake. However, little information is available on the capability of gastric cells to synthesize, release and respond to serotonin by functional changes of mechanisms regulating gastric acid secretion. We investigated whether human gastric cells are capable of serotonin synthesis and release. First, HGT-1 cells, derived from a human adenocarcinoma of the stomach, and human stomach specimens were immunostained positive for serotonin. In HGT-1 cells, incubation with the tryptophan hydroxylase inhibitor p-chlorophenylalanine reduced the mean serotonin-induced fluorescence signal intensity by 27%. Serotonin release of 147 ± 18%, compared to control HGT-1 cells (set to 100%) was demonstrated after treatment with 30 mM of the satiating amino acid L-Arg. Granisetron, a 5-HT3 receptor antagonist, reduced this L-Arg-induced serotonin release, as well as L-Arg-induced proton secretion. Similarly to the in vitro experiment, human antrum samples released serotonin upon incubation with 10 mM L-Arg. Overall, our data suggest that human parietal cells in culture, as well as from the gastric antrum, synthesize serotonin and release it after treatment with L-Arg via an HTR3-related mechanism. Moreover, we suggest not only gastric distension but also gastric acid secretion to result in peripheral serotonin release. 相似文献
972.
973.
Adrien Gurard Victor Laurent Gaëlle Fromont David Estve Julia Gilhodes Edith Bonnelye Sophie Le Gonidec Philippe Valet Bernard Malavaud Nicolas Reina Camille Attan Catherine Muller 《International journal of molecular sciences》2021,22(4)
Bone metastasis remains the most frequent and the deadliest complication of prostate cancer (PCa). Mechanisms leading to the homing of tumor cells to bone remain poorly characterized. Role of chemokines in providing navigational cues to migrating cancer cells bearing specific receptors is well established. Bone is an adipocyte-rich organ since 50 to 70% of the adult bone marrow (BM) volume comprise bone marrow adipocytes (BM-Ads), which are likely to produce chemokines within the bone microenvironment. Using in vitro migration assays, we demonstrated that soluble factors released by human primary BM-Ads are able to support the directed migration of PCa cells in a CCR3-dependent manner. In addition, we showed that CCL7, a chemokine previously involved in the CCR3-dependent migration of PCa cells outside of the prostate gland, is released by human BM-Ads. These effects are amplified by obesity and ageing, two clinical conditions known to promote aggressive and metastatic PCa. In human tumors, we found an enrichment of CCR3 in bone metastasis vs. primary tumors at mRNA levels using Oncomine microarray database. In addition, immunohistochemistry experiments demonstrated overexpression of CCR3 in bone versus visceral metastases. These results underline the potential importance of BM-Ads in the bone metastatic process and imply a CCR3/CCL7 axis whose pharmacological interest needs to be evaluated. 相似文献
974.
Paul Marczynski Myriam Meineck Ning Xia Huige Li Daniel Kraus Wilfried Roth Tamara Mckel Simone Boedecker Andreas Schwarting Julia Weinmann-Menke 《International journal of molecular sciences》2021,22(5)
Background: Systemic lupus erythematosus (SLE) is a chronic inflammatory autoimmune disease and patients are under an increased risk for cardiovascular (CV) events and mortality. The increased CV risk for patients with SLE seems to be caused by a premature and accelerated atherosclerosis, attributable to lupus-specific risk factors (i.e., increased systemic inflammation, altered immune status), apart from traditional CV risk factors. To date, there is no established experimental model to explore the pathogenesis of this increased CV risk in SLE patients. Methods: Here we investigated whether MRL-Faslpr mice, which develop an SLE-like phenotype, may serve as a model to study lupus-mediated vascular disease. Therefore, MRL-Faslpr, MRL-++, and previously generated Il6−/− MRL-Faslpr mice were used to evaluate vascular changes and possible mechanisms of vascular dysfunction and damage. Results: Contrary to MRL-++ control mice, lupus-prone MRL-Faslpr mice exhibited a pronounced vascular and perivascular leukocytic infiltration in various organs; expression of pro-inflammatory cytokines in the aorta and kidney was augmented; and intima-media thickness of the aorta was increased. IL-6 deficiency reversed these changes and restored aortic relaxation. Conclusion: Our findings demonstrate that the MRL-Faslpr mouse model is an excellent tool to investigate vascular damage in SLE mice. Moreover, IL-6 promotes vascular inflammation and damage and could potentially be a therapeutic target for the treatment of accelerated arteriosclerosis in SLE. 相似文献
975.
Stephan Dreschers Kim Ohl Julia Mllmann Klaus Tenbrock Thorsten W. Orlikowsky 《International journal of molecular sciences》2021,22(8)
MΦ differentiate from circulating monocytes (Mo). The reduced ability of neonatal Mo to undergo apoptosis after E. coli infection (phagocytosis-induced cell death (PICD)) could contribute to sustained inflammatory processes. The objective of our study was to investigate whether immune metabolism in Mo can be modified to gain access to pro-apoptotic signaling. To this end, we supplemented Mo from neonates and from adults with the branched amino acid leucine. In neonatal Mo, we observed increased energy production via oxidative phosphorylation (Oxphos) after E. coli infection via Seahorse assay. Leucine did not change phagocytic properties. In neonatal Mo, we detected temporal activation of the AKT and mTOR pathways, accompanied with subsequent activation of downstream targets S6 Kinase (S6K) and S6. FACS analyses showed that once mTOR activation was terminated, the level of anti-apoptotic BCL-2 family proteins (BCL-2; BCL-XL) decreased. Release of cytochrome C and cleavage of caspase-3 indicated involvement of the intrinsic apoptotic pathway. Concomitantly, the PICD of neonatal Mo was initiated, as detected by hypodiploid DNA. This process was sensitive to rapamycin and metformin, suggesting a functional link between AKT, mTOR and the control of intrinsic apoptotic signaling. These features were unique to neonatal Mo and could not be observed in adult Mo. Supplementation with leucine therefore could be beneficial to reduce sustained inflammation in septic neonates. 相似文献
976.
Julia N. Cheng Jennifer B. Frye Susan A. Whitman Andrew G. Kunihiro Ritu Pandey Janet L. Funk 《International journal of molecular sciences》2021,22(9)
While tumoral Smad-mediated transforming growth factor β (TGFβ) signaling drives osteolytic estrogen receptor α-negative (ER-) breast cancer bone metastases (BMETs) in preclinical models, its role in ER+ BMETs, representing the majority of clinical BMETs, has not been documented. Experiments were undertaken to examine Smad-mediated TGFβ signaling in human ER+ cells and bone-tropic behavior following intracardiac inoculation of estrogen (E2)-supplemented female nude mice. While all ER+ tumor cells tested (ZR-75-1, T47D, and MCF-7-derived) expressed TGFβ receptors II and I, only cells with TGFβ-inducible Smad signaling (MCF-7) formed osteolytic BMETs in vivo. Regulated secretion of PTHrP, an osteolytic factor expressed in >90% of clinical BMETs, also tracked with osteolytic potential; TGFβ and E2 each induced PTHrP in bone-tropic or BMET-derived MCF-7 cells, with the combination yielding additive effects, while in cells not forming BMETs, PTHrP was not induced. In vivo treatment with 1D11, a pan-TGFβ neutralizing antibody, significantly decreased osteolytic ER+ BMETs in association with a decrease in bone-resorbing osteoclasts at the tumor-bone interface. Thus, TGFβ may also be a driver of ER+ BMET osteolysis. Moreover, additive pro-osteolytic effects of tumoral E2 and TGFβ signaling could at least partially explain the greater propensity for ER+ tumors to form BMETs, which are primarily osteolytic. 相似文献
977.
978.
979.
Michael Ablinger Thomas Lettner Nicole Friedl Hannah Potocki Theresa Palmetzhofer Ulrich Koller Julia Illmer Bernadette Liemberger Stefan Hainzl Alfred Klausegger Manuela Reisenberger Jo Lambert Mireille Van Gele Eline Desmet Els Van Maelsaeke Monika Wimmer Roland Zauner Johann W. Bauer Verena Wally 《International journal of molecular sciences》2021,22(7)
Intermediate junctional epidermolysis bullosa caused by mutations in the COL17A1 gene is characterized by the frequent development of blisters and erosions on the skin and mucous membranes. The rarity of the disease and the heterogeneity of the underlying mutations renders therapy developments challenging. However, the high number of short in-frame exons facilitates the use of antisense oligonucleotides (AON) to restore collagen 17 (C17) expression by inducing exon skipping. In a personalized approach, we designed and tested three AONs in combination with a cationic liposomal carrier for their ability to induce skipping of COL17A1 exon 7 in 2D culture and in 3D skin equivalents. We show that AON-induced exon skipping excludes the targeted exon from pre-mRNA processing, which restores the reading frame, leading to the expression of a slightly truncated protein. Furthermore, the expression and correct deposition of C17 at the dermal–epidermal junction indicates its functionality. Thus, we assume AON-mediated exon skipping to be a promising tool for the treatment of junctional epidermolysis bullosa, particularly applicable in a personalized manner for rare genotypes. 相似文献
980.
Joseph Z. Hamilton Thomas A. Pires Jamie A. Mitchell Julia H. Cochran Kim K. Emmerton Margo Zaval Ivan J. Stone Martha E. Anderson Steven Jin Dr. Andrew B. Waight Dr. Robert P. Lyon Dr. Peter D. Senter Dr. Scott C. Jeffrey Dr. Patrick J. Burke 《ChemMedChem》2021,16(7):1077-1081
Tubulysins have emerged in recent years as a compelling drug class for delivery to tumor cells via antibodies. The ability of this drug class to exert bystander activity while retaining potency against multidrug-resistant cell lines differentiates them from other microtubule-disrupting agents. Tubulysin M, a synthetic analogue, has proven to be active and well tolerated as an antibody-drug conjugate (ADC) payload, but has the liability of being susceptible to acetate hydrolysis at the C11 position, leading to attenuated potency. In this work, we examine the ability of the drug-linker and conjugation site to preserve acetate stability. Our findings show that, in contrast to a more conventional protease-cleavable dipeptide linker, the β-glucuronidase-cleavable glucuronide linker protects against acetate hydrolysis and improves ADC activity in vivo. In addition, site-specific conjugation can positively impact both acetate stability and in vivo activity. Together, these findings provide the basis for a highly optimized delivery strategy for tubulysin M. 相似文献